Skip to content

Ranger™ H74939733420020Recalls & reported problems

Boston Scientific Corporation · MONORAIL™ Paclitaxel-Coated PTA Balloon Catheter · Class 3

All models of Ranger (50)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00191506046675), received between Jan 20, 2026 and Mar 2, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Entrapment of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Entrapment of Device1
  • Material Rupture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 2, 2026Material Rupture

    IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED RIGHT SUPERFICIAL FEMORAL ARTERY. A 4.0 X 200 MM 200CM RANGER DRUG-COATED BALLOON CATHETER BALLOON WAS ADVANCED FOR DILATION. HOWEVER, IT WAS NOTED THAT THE BALLOON RUPTURED DURING THE FIRST INFLATION. THE DEVICE WAS REMOVED WITHOUT ANY PROBLEM USING THE NORMAL METHOD, AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT, AND THE PATIENT WAS IN GOOD CONDITION POST-PROCEDURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24480468 ↗
  • MalfunctionJan 20, 2026Entrapment of Device

    IT WAS REPORTED THAT STUCK ON GUIDEWIRE OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MILDLY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 4.0 X 200 MM 200CM RANGER PACLITAXEL-COATED PTA BALLOON CATHETER WAS SELECTED FOR USE DURING THIS ENDOVASCULAR THERAPY PROCEDURE. DURING THE PROCEDURE, THE RANGER DEVICE BECAME STUCK WITH A NON-BOSTON SCIENTIFIC GUIDEWIRE. IT WAS NOTED THAT THE GUIDEWIRE WAS INSERTED FROM THE TIP OF THE BALLOON AND THE GUIDEWIRE APPEARED FROM THE EXIT PORT. WHEN IT WAS ADVANCED FURTHER AND TRIED TO BE INSERTED INTO THE SHEATH, IT BECAME STIFF, AND THE GUIDEWIRE COULD NO LONGER BE ADVANCED. THE GUIDEWIRE WAS REMOVED FROM THE BALLOON, AND THE SURFACE OF THE GUIDEWIRE WAS WIPED AND WAS REINSERTED. HOWEVER, IT WOULD NO LONGER COME OUT FROM THE EXIT PORT; THEREFORE, A DIFFERENT DEVICE OF THE SAME SIZE WAS USED, AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24121714 ↗

Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices

All Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page